Skip to content

Clinical trials

Alzheimer Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: China Clear all

238 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20061
20073
20084
20103
20114
20126
20132
20143
20153
20165
20178
20186
201913
202018
202115
202222
202317
202438
202536
202629

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting88
Completed55
Unknown status49
Not yet recruiting22
Active, not recruiting9
Terminated8
Enrolling by invitation3
Withdrawn3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xuanwu Hospital, Beijing23
Capital Medical University9
Ruijin Hospital9
Shanghai Mental Health Center8
Eli Lilly and Company7
Anhui Medical University6
First Affiliated Hospital of Zhejiang University6
Hoffmann-La Roche6
Dongzhimen Hospital, Beijing5
XuanwuH 25

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease238
Cognitive Dysfunction49
Dementia27
Neurodegenerative Diseases13
Nervous System Diseases7
Parkinson Disease7
Lewy Body Disease6
Mental Disorders6
Plaque, Amyloid6
Anxiety Disorders5

Trials

Showing 1 to 25 of 238. Each trial links to its page on Pharma Observatory.

138 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.